• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC
Click for more information
6.98% 9.2¢

IMMURON LIMITED - Charts / Financials

Market Cap $21.31M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 9.5¢   Day High 9.8¢   Day Low 8.8¢
Daily Volume 3101195
Bids   Sellers
Number Price Volume   Number Price Volume
1 9.1¢ 10000   1 9.2¢ 8000

Directors & Senior Management

Mr. Steven Lydeamore Chief Executive Officer
Mr. Phillip Hains Chief Financial Officer, Company Secretary
Dr. Jerry Kanellos Chief Operating Officer
Mr. Paul Brennan Non-Executive Independent Chairman of the Board
Dr. Jeannette Joughin Non-Executive Director
Mr. Daniel Pollock Non-Executive Independent Director
Prof. Ravi Savarirayan Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
9.2¢ 		Change
0.006(6.98%) 		Mkt cap ! $21.31M
Open High Low Value Volume
9.5¢ 9.8¢ 8.8¢ $289.8K 3.101M

Buyers (Bids)

No. Vol. Price($)
1 10000 9.1¢
 

Sellers (Offers)

Price($) Vol. No.
9.2¢ 8000 1
View Market Depth
Last trade - 15.55pm 17/01/2025 (20 minute delay) ?

Top Stories

Insignia Financial bags revised bid from CC Capital

Insignia Financial (ASX:IFL) has received a revised non-binding and indicative proposal from CC Capital Partners.
Lynas sales revenues up in Q2 of FY 2025, but lower production fuels share price slump Lynas Rare Earths Ltd has seen its share price drop 5.5% after releasing quarterly activities report in which it noted lower production
Lightning Minerals ready to drill with spodumene confirmed in Brazil Lightning Minerals Ltd has confirmed the presence of spodumene mineralisation through Raman spectrographic analysi
Looking ahead to a year of intriguing investment opportunities The New Year brings renewed energy, exciting opportunities, and the promise of growth. But will the market maintain its upward momentum?
Rio shares drop 1% on talk of Glencore merger Rio Tinto has been trading down on reports that the mining titan could be in merger discussions with Glencore.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.